Sharda Cropchem (SHARDACROP) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
3 Feb, 2026Executive summary
Q3 FY25 revenue rose 47% year-over-year to INR 929 crores, driven by a 49% increase in overall volumes, with the agrochemical segment up 50% and non-agrochemical up 42%.
EBITDA for Q3 FY25 surged 232% to INR 157 crores, with a margin of 16.9%; PAT reached INR 31 crores, up from INR 4.6 crores in Q3 FY24.
9M FY25 revenue increased 35% year-over-year to INR 2,491 crores, with agrochemical up 46% and non-agrochemical down 4%.
The company operates an asset-light, IP-driven model, focusing on global marketing and distribution of generic crop protection chemicals.
Interim dividend of INR 3 per equity share declared for FY25.
Financial highlights
Q3 FY25: Revenue INR 929 crores (+47% YoY), gross margin 32.7% (+660 bps YoY), EBITDA INR 157 crores (+232% YoY), EBITDA margin 16.9%, PAT INR 31 crores.
9M FY25: Revenue INR 2,491 crores (+35% YoY), gross margin 30%, EBITDA INR 330 crores, EBITDA margin 13.2%, PAT INR 101 crores (vs loss of INR 112 crores in 9M FY24).
EPS for Q3 FY25 was INR 3.45; for 9M FY25, INR 11.17.
Working capital days improved to 98 days, down 60 days from March 2024.
Net debt-free with INR 742 crores in cash and liquid investments as of December 31, 2024.
Outlook and guidance
Management expects Q4 and FY26 to maintain high growth momentum, with FY25 EBITDA margin guidance of 15%-18%.
Revenue for FY25 projected to reach around INR 4,000 crores, with Q4 expected to outperform last year.
Focus on forward integration by building sales force and expanding distribution in key markets.
Continued investment in product registrations and operational efficiencies to drive margin improvements.
Agrochemicals segment is seasonal, with performance influenced by cropping patterns and global weather conditions.
Latest events from Sharda Cropchem
- Q1 FY25 delivered 23% revenue growth and a return to profitability with strong agrochemical gains.SHARDACROP
Q1 24/253 Feb 2026 - Record PAT and revenue growth, margin gains, and Rs. 6.00 interim dividend declared.SHARDACROP
Q3 25/262 Feb 2026 - Q2 FY2025 revenue up 34% YoY, margins improved, and guidance set at 15%-18% growth for FY2025.SHARDACROP
Q2 24/2518 Jan 2026 - Q2 and H1 FY26 delivered strong revenue, profit, and margin growth, led by agrochemicals.SHARDACROP
Q2 25/2629 Dec 2025 - FY25 saw strong profit and margin growth, with over 15% top-line growth targeted for FY26.SHARDACROP
Q4 24/2518 Nov 2025 - Q1 FY26 saw 25% revenue growth, 67% EBITDA growth, and over 4x PAT, with strong global demand.SHARDACROP
Q1 25/2616 Nov 2025